Insider Transactions Reported by 15 Insiders of CITIUS ONCOLOGY, INC.

Symbol
CTOR on Nasdaq
Location
Cranford, NJ

There are no Buy or Sell transactions made by insiders since 23 Dec 2024

CITIUS ONCOLOGY, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Leonard L. Mazur Chief Executive Officer, Director $9.79M 19 Sep 2025
MYRON Z. HOLUBIAK Secretary, Director $4.27M 19 Sep 2025
Myron Czuczman Chief Medical Officer $3.92M 19 Sep 2025
Jaime Bartushak Chief Financial Officer $3.92M 19 Sep 2025
Joel David Mayersohn Director $911K 19 Sep 2025
Eugene Myron Holuka Director $677K 19 Sep 2025
Carol Webb Director $677K 19 Sep 2025
DENNIS M. MCGRATH Director $677K 19 Sep 2025
Suren G. Dutia Director $677K 19 Sep 2025
Robert Joseph Smith Director $624K 19 Sep 2025
Citius Pharmaceuticals, Inc. 10%+ Owner 12 Aug 2024
Dahe Zhang Chief Financial Officer, Director, 10%+ Owner 13 Oct 2022
Brian Hartzband Director 13 Oct 2022
Xiaofeng Yuan Chief Executive Officer, Director, 10%+ Owner 13 Oct 2022
Cathy Jiang Director 13 Oct 2022

Recent Insider Transactions by Companies or Individuals for CITIUS ONCOLOGY, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.